-
United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
-
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
-
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
-
United Therapeutics (UTHR) Announces $1 Billion Accelerated Share Repurchase Program
-
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
-
Pre-Open Movers 09/04: (MNKD) (REPH) (ORIG) Higher; (TAHO) (EYEG) (NKE) Lower (more...)
-
UPDATE: GlaxoSmithKline (GSK) Said Exploring Takeover of United Therapeutics (UTHR), Gilead (GILD) Seen as Front-runner - Standard
-
United Therapeutics (UTHR) Enters Accelerated Share Repurchase Agreement
-
Pre-Open Stock Movers 12/23: (DRCO) (XRTX) (APPL) Higher; (TSRO) (MU) (TIF) Lower (more...)
-
Notable Analyst Rating Changes 09/15: (AMAT) (ACI) (MT) Upgraded; (ILMN) (ARX) (UTHR) Downgraded
-
Citi Downgrades United Therapeutics Corp. (UTHR) to Hold
-
Citi Cuts United Therapeutics Corp. (UTHR) to Hold
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)
-
Morning Movers 3/16: Beaten-Up Bank Stocks Up Again (C, BAC); SanDisk (SNDK) Drops On Negative Analyst Comments
-
Notable Analyst Rating Changes 3/3: DWA, BBD, ARO Upgraded; UBS, CS, DHI, CTX, GENZ Downgraded
-
Morning Movers 11/17: United Therapeutics (UTHR) Sinks On Drug Failure, Las Vegas Sands (LVS) Up On Auditor Commnets

